CORC  > 南华大学
Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin-resistant breast cancer by binding to enhancer of zeste homolog 2
Jiang, Baohong; Li, Yuehua*; Qu, Xiaofei; Zhu, Hongbo; Tan, Yeru; Fan, Qun; Jiang, Yiling; Liao, Mingchu; Wu, Xiaoping
刊名International Journal of Molecular Medicine
2018
卷号42期号:5页码:2801-2810
关键词breast cancer drug-resistance cancer susceptibility candidate 9 enhancer of zeste homolog 2 multidrug resistance protein 1
ISSN号1107-3756
DOI10.3892/ijmm.2018.3812
URL标识查看原文
WOS记录号WOS:000447702700042
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5677350
专题南华大学
作者单位[Jiang, Baohong] Univ South China, Affiliated Hosp 1, Dept Pharm, Hengyang 421001, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Jiang, Baohong,Li, Yuehua*,Qu, Xiaofei,et al. Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin-resistant breast cancer by binding to enhancer of zeste homolog 2[J]. International Journal of Molecular Medicine,2018,42(5):2801-2810.
APA Jiang, Baohong.,Li, Yuehua*.,Qu, Xiaofei.,Zhu, Hongbo.,Tan, Yeru.,...&Wu, Xiaoping.(2018).Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin-resistant breast cancer by binding to enhancer of zeste homolog 2.International Journal of Molecular Medicine,42(5),2801-2810.
MLA Jiang, Baohong,et al."Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin-resistant breast cancer by binding to enhancer of zeste homolog 2".International Journal of Molecular Medicine 42.5(2018):2801-2810.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace